Inspired by a real patient.

How does it work?1,2

ELIGARD® is an androgen deprivation therapy (ADT) that helps lower testosterone levels, which may slow the growth of prostate cancer.

Learn More

Personalized dosing1

You and your doctor have 4 dosing options to choose from.

Learn More

Educational resources

Comprehensive resources are available to you as you navigate your journey with prostate cancer.

Learn More
Man and a woman standing next to a nurse with a clipboard

Patient considerations

Your ADT should fit into your lifestyle—consider things like:
  • personalized dosing
  • route of administration
  • other medications you might be taking
  • financial support
  • additional resources

Did you know?

3.3M

Men in the US are still alive today after receiving a prostate cancer diagnosis3

67

Is the average age of diagnosis3

70%

The increased risk of African American men developing prostate cancer compared to non-Hispanic white men4

1 in 8

Men in the US will be diagnosed with prostate cancer in their lifetime, making it the most diagnosed cancer in men in 20244

Want to learn more about ELIGARD? 

Discover More 
References: 1. ELIGARD (leuprolide acetate). Prescribing Information. Tolmar, Inc. 2024. 2. NCCN Guidelines for Patients®: Advanced-Stage Prostate Cancer. National Comprehensive Cancer Network; 2024. 3. Key statistics for prostate cancer. American Cancer Society. Updated January 19, 2024. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html 4. Cancer Facts & Figures 2024. American Cancer Society; 2024.

Other links

You are now leaving ELIGARD.com.

Are you sure you want to leave? 

YES
NO

You are now navigating to the healthcare provider site.

Are you a healthcare provider?

YES
NO
Skip to content